使用机器学习和传播模型预测错误折叠的蛋白质在阿尔茨海默病中传播
Luca Gherardini1, Aleksandra Zajdel1, Lorenzo Pini2
1Computer Vision Data Science Group, Sano centre for computational medicine, Czarnowiejska 36, Krakow 30-054, Poland.
Cerebral cortex (New York, N.Y. : 1991)
|October 14, 2023
概括
机器学习模型预测阿尔茨海默病 (AD) 患者的粉样β蛋白水平. 这些模型为规划治疗提供了宝贵的工具,特别是对于无症状患者.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 医疗信息学 医疗信息学
背景情况:
- 阿尔茨海默病 (AD) 对老龄化人口构成了重大挑战.
- 错误折叠的蛋白质,特别是粉样蛋白-β (Aβ) 和,都与阿尔茨海默病的发病有关.
- 传统的蛋白质扩散模拟模型需要经验参数估计.
研究的目的:
- 开发和比较用于预测Aβ度的机器学习方法.
- 评估这些模型在临床应用中的实际有效性.
- 为医生和研究人员提供一个网络服务,让他们利用这些预测工具.
主要方法:
- 采用了一个受结构连接限制的自回归模型.
- 图形卷积网络 (GCN) 被用作第二种机器学习方法.
- 模型性能与已建立的模拟模型进行了比较.
主要成果:
- 与最先进的模型相比,自回归模型表现出更高的性能.
- 使用自回归方法实现了较低的预测误差.
- 这些模型显示了预测Aβ度在基线后两年的潜力.
结论:
- 机器学习为AD中蛋白质扩散建模提供了传统模拟的可行替代方案.
- 预测的Aβ度可以帮助治疗计划,特别是对无症状患者.
- 虽然Aβ预测不是唯一的预后指标,但它有助于制定治疗策略.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
503
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
503


